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Should All Comatose Cardiac Arrest Survivors
Go to the Cath Lab?*R. David Anderson, MD, MSM ajor progress in the treatment of coronaryartery disease has been made over thepast several decades. Yet in 2014, coro-
nary heart disease (CHD) remains the leading cause
of death worldwide. The ﬁrst manifestation of CHD
in at least 50% of patients is sudden cardiac death
(SCD); it most often occurs unexpectedly, within 6 h
of symptom onset and usually outside of the hospital
setting. In the United States, SCD is estimated to
occur in 300,000 to 350,000 patients annually (1).
Approximately 80% of all SCDs are due to CHD, and
this incidence has not decreased over the past several
decades despite the decrease in age-adjusted CHD
mortality in the United States. Although progress
has been made in treating survivors of SCD, the
outcomes in this population remain poor. A recent
meta-analysis of global studies of out-of-hospital car-
diac arrest (OHCA) demonstrated worldwide differ-
ences in survival to discharge, but rates remain very
low at only 2.2 to 10.7% (2).
KNOWLEDGE GAPS IN SCD
No adequate risk prediction models for SCD exist.
Traditional risk factors for atherosclerosis, such as
those in the Framingham Risk Index, provide insight
into populations, leading to primary prevention
strategies that have affected mortality. They are less
helpful for individual SCD risk prediction, likely due
to very low event rates. Risk prediction improves in*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
From the Division of Cardiovascular Medicine, University of Florida,
Gainesville, Florida. Dr. Anderson is a consultant for Biosense Webster,
Inc., a Johnson & Johnson Company.patients with established disease, but only modestly
(3). Electrophysiological, anatomic, autonomic, and
genetic markers have been proposed to improve
individual risk prediction, but none have yet proved
clinically useful.
Differences between the sexes remain poorly
understood. Among patients with signs and symp-
toms of ischemic heart disease, women more often
than men have nonobstructive coronary artery dis-
ease (4). Differences also exist in the pathology of
women with SCD. Fewer women with SCD demon-
strate CHD as the underlying etiology of their event.
Among those with obstructive CHD, younger women
more often have plaque erosion versus plaque
rupture. Plaque rupture is the more common pa-
thology found in older women with SCD, as it is in
men. Curiously, smoking is more often associated
with plaque erosion in younger women and plaque
rupture in men (5). Dissimilarities may also exist in
the hormone levels of patients with SCD, possibly
inﬂuencing their risk proﬁle, but mechanistic expla-
nations are lacking (6). Even a woman’s proximity to
roadways has been linked to an increased risk of
SCD, a possible surrogate for air pollution and
roadway noise (7).
RESUSCITATION FROM CARDIAC ARREST
At the time of SCD, survival to hospital discharge is
improved with bystander cardiopulmonary resusci-
tation, the presence of ventricular tachycardia or
ﬁbrillation, if the arrest is witnessed, or by the
return of spontaneous circulation (ROSC) (8). Newer
approaches such as cardiocerebral resuscitation and
“Take Heart America” have led to improvements in
survival (9,10). Some accepted techniques for re-
suscitation, however, have come under scrutiny. An
observational study comparing advanced life support
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1042with basic life support in Medicare beneﬁciaries with
OHCA suggested both survival to hospital discharge
(13.1% vs. 9.2%; 3.9 percentage point difference [95%
conﬁdence interval: 2.3 to 5.7]) and neurological
outcomes (8.0% vs. 5.4%; 2.6 percentage point dif-
ference [95% conﬁdence interval: 1.2 to 4.0]) were
better with basic life support versus advanced life
support, respectively (11). In another study, of 1,134
OHCA patients who achieved ROSC, pre-hospital use
of epinephrine was associated with worse survival in
a dose-dependent fashion (12). These data reinforce
the high mortality of OHCA patients and the ongoing
need for further research into improvements in the
care of SCD patients.
POST-RESUSCITATION TREATMENT
The optimal treatment of OHCA survivors is not fully
deﬁned (Table 1). Two main goals of post-resuscitation
care are the preservation of neurological function
and limiting cardiac failure. Therapeutic hypothermia
(TH) has emerged as a viable strategy to improve
neurological outcomes. After randomized clinical tri-
als in 2002, the International Liaison Committee for
Resuscitation and the American Heart Association
endorsed TH, cooling to a core temperature of 33C to
36C, for all comatose OHCA survivors (13). Perhaps
due to logistical issues, health care systems have
been slow to adopt its use.
Coronary artery disease is the other target. In-
vestigators have identiﬁed a high prevalence of both
CHD and occluded coronary arteries in comatose
OHCA survivors (14). Without randomized trials,
available evidence suggests that post–cardiac arrest
patients with ST-segment elevation have better
survival-to-discharge and neurological outcomes if
triaged to coronary angiography with percutaneous
coronary intervention as appropriate (15). Less clear is
how to treat patients who have achieved ROSC and
remain comatose, but no ST-segment elevation is
seen on their electrocardiogram.
In one of the largest studies to date, Kern et al. (16),
in this issue of JACC: Cardiovascular Interventions,TABLE 1 Management of Post–Cardiac Arrest Survivors
Therapeutic
Hypothermia
Immediate
Angiography
ST-segment elevation
Comatose Recommended Recommended
Noncomatose Recommended Recommended
No ST-segment elevation
Comatose Recommended Unclear
Noncomatose Recommended Unclearfollowed 746 comatose post–cardiac arrest patients
enrolled in the International Cardiac Arrest Registry
Cardiology Database. Remarkably, 98% of these pa-
tients were treated with TH. Survival to hospital
discharge was greatest among patients with ST-
segment elevation, presumably a result of immediate
angiography with percutaneous coronary interven-
tion as indicated. Fewer patients without ST-segment
elevation underwent immediate angiography (45.1%
vs. 96.9%; p < 0.0001), but survival to hospital
discharge was no different than in the ST-segment
elevation cohort (57.9% vs. 54.7%; p ¼ 0.60). Survival
was poor in both groups without immediate coronary
angiography (20.3% vs. 33.3%; p ¼ 0.61). Favorable
neurological outcomes were seen in most survivors,
but among those without ST-segment elevation, the
use of coronary angiography predicted better func-
tional outcomes.LIMITATIONS/CONTRIBUTIONS
One of the more challenging triage decisions for the
interventional cardiologist is when to take comatose
post–cardiac arrest patients with ROSC to the cathe-
terization laboratory. That decision is easier when
ST-segment elevation is present. The data from
Kern et al. (16), although favorable for the group
without ST-segment elevation, should be interpreted
cautiously. The patient population was heteroge-
neous, with only 79% OHCA patients. Were the other
21% in-hospital cardiac arrest patients whose event
was related to surgery, trauma, or another cause? The
underlying etiology of these events is likely different,
and including them makes generalization to the
OHCA population difﬁcult.
The stated aim of the study was to “determine
whether immediate coronary angiography after
resuscitation was associated with improved survival
in those with and without STEMI.” The use of im-
mediate coronary angiography differed signiﬁcantly
by enrolling center and by the patient’s clinical
presentation. This analysis initially dichotomized
patients into those who did and did not have an
STEMI, only then dissecting further to see the effect
of immediate angiography. Physicians might have
been more informed by a strategy directly com-
paring patients undergoing immediate coronary
angiography with those who did not, regardless of
the electrocardiographic ﬁndings.
The limitations of registry data are highlighted by
the higher survival rate of patients who underwent
delayed coronary angiography, as shown in their
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1043Table 2 (16), compared with those undergoing im-
mediate coronary angiography. Although this likely
represents selection bias, it emphasizes the need for a
randomized comparison. Finally, the majority of pa-
tients in the current study were men. Whether the
data from Kern et al. (16) also apply to women would
be useful information.
Kern et al. (16) add to a growing body of evidence
suggesting that, in the absence of an identiﬁable
noncardiac cause, patients remaining comatose
despite ROSC after cardiac arrest should be consideredfor immediate coronary angiography regardless of the
presence of ST-segment elevation. The DISCO (Direct
or Subacute Coronary Angiography for Out-of-hospital
Cardiac Arrest) trial is currently enrolling and should
help to clarify this further (NCT02309151).
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